US FDA approval of Zealand Pharma A/S’s Zegalogue headlined a quiet week – and brought the Center for Drug Evaluation and Research’s novel approval count for 2021 to 14.
Merck & Co., Inc.’s juggernaut Keytruda added a second esophageal carcinoma claim
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?